Skip to main content
    T

    Teva Pharma Industries Ltd ADR (TEVA)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE

    $42.61
    +0.04 (+0.09%)

    Market Cap: $51.92B

    Last updated: Nov 17, 2026 at 4:32 PM ET

    Teva Pharma Industries Ltd ADR (TEVA) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Teva Pharma Industries Ltd ADR (TEVA) has a latest price of $42.61 on Nov 17, 2026, 4.4% below its 52-week high of $44.57. Its price rose 67.7% over the past 12 months. The month-end price fell 1.5% over the 10 years through Oct 2026, a compound annual decline of 0.2%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $42.74 in Oct 2016 and its lowest $6.88 in Sep 2019, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart TEVA with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for TEVA.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 13.7%, and over 6 months it rose 25.1%. The month-end price rose 390.6% over the 3 years through Oct 2026, a compound annual rate of 69.9%.

    PeriodChange
    1 month+3.1%
    3 months+13.7%
    6 months+25.1%
    12 months+67.7%
    12 months, with dividends+67.7%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+390.6%+69.9%
    5 years+381.6%+36.9%
    10 years-1.5%-0.2%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2024, when the price rose 111.1%, and its weakest was 2017, when it fell 47.7%.

    YearCloseChange
    2026 through Oct 2026$42.09+34.9%
    2025$31.21+41.6%
    2024$22.04+111.1%
    2023$10.44+14.5%
    2022$9.12+13.9%
    2021$8.01-17.0%
    2020$9.65-1.5%
    2019$9.80-36.4%
    2018$15.42-18.6%
    2017$18.95-47.7%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 5.4% above its 50-day average of $40.42 and 21.1% above its 200-day average of $35.18.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$42.61
    52-week high$44.57-4.4%
    52-week low$24.01+77.5%
    50-day average$40.42+5.4%
    200-day average$35.18+21.1%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 43.7%.

    MeasureValue
    1-year beta0.61
    Largest fall, 1 year-21.8%
    Largest fall, 3 years-43.7%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Valuation

    Teva Pharma Industries Ltd ADR traded at 10.8x earnings at the end of 2025, against a 5-year median of 5.7x and a 10-year median of 4.7x.

    TEVA valuation history

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About TEVA

    What is TEVA's 1-year price change?

    Teva Pharma Industries Ltd ADR's price rose 67.7% over the past 12 months. With dividends included, the 12-month total return was 67.7%.

    What is TEVA's 5-year price change?

    Teva Pharma Industries Ltd ADR's month-end price rose 381.6% over the 5 years through Oct 2026, a compound annual rate of 36.9%. These figures leave out dividends.

    What is TEVA's 52-week high and low?

    Teva Pharma Industries Ltd ADR's 52-week high is $44.57 and its 52-week low is $24.01. Its latest price of $42.61 on Nov 17, 2026 is 4.4% below the high.

    What is TEVA's beta?

    Teva Pharma Industries Ltd ADR's 1-year beta against the S&P 500 is 0.61, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 21.8%.

    Is the TEVA chart free?

    Yes. Advanced Charting for TEVA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.